Drug Profile
LY 300168
Alternative Names: GYKI 53655Latest Information Update: 14 Sep 2000
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals; Eli Lilly and Company
- Developer Eli Lilly and Company
- Class Antiepileptic drugs; Benzodiazepines; Muscle relaxants; Neuroprotectants; Small molecules
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Opioid-related disorders
Most Recent Events
- 14 Sep 2000 Discontinued-Preclinical for Neuroprotection in USA (Unknown route)
- 14 Sep 2000 Discontinued-Preclinical for Opioid abuse in USA (Unknown route)
- 18 Feb 1999 Preclinical development for Neuroprotection in USA (Unknown route)